Transferrin receptor-1 and 2 expression in chronic lymphocytic leukemia
| Autor: | Ioanna Chiotoglou, Anastasia Hadzidimitriou, Aliki Tsompanakou, George Paterakis, Ioanna Athanasiadou, Niki Stavroyianni, Athanasios Fassas, Nikolaos Stathakis, Chrysoula Belessi, Vassiliki Douka, Tatjana Smilevska, Riad Saloum, Maria Samara, Nikolaos Laoutaris, Kostas Stamatopoulos, Achilles Anagnostopoulos, Anastasia Athanasiadou, Panagoula Kollia |
|---|---|
| Rok vydání: | 2006 |
| Předmět: |
Adult
Antigens Differentiation T-Lymphocyte Male Cancer Research Chronic lymphocytic leukemia Transferrin receptor Biology Immunophenotyping Antigens CD immune system diseases hemic and lymphatic diseases Receptors Transferrin medicine Humans Lectins C-Type RNA Messenger Beta (finance) Aged Messenger RNA Hematology Middle Aged medicine.disease ADP-ribosyl Cyclase 1 Leukemia Lymphocytic Chronic B-Cell Molecular biology Oncology Mutation Immunology Female Immunoglobulin Heavy Chains |
| Zdroj: | Leukemia Research. 30:183-189 |
| ISSN: | 0145-2126 |
| Popis: | Transferrin receptor (TfR)-1 and 2 mRNA and CD71 (TfR1) expression was analyzed in 118 CLL patients. Ninety-five out of 109 analyzed cases expressed CD71, mostly at a high level; 60% of CD71 (+) cases were IGH-mutated. All samples were TfR1 mRNA (+); TfR2-alpha/beta mRNA was detected in, respectively, 52/102 and 100/109 cases. Competitive RT-PCR showed widely divergent levels of TfR1 mRNA in cases with high CD71 expression, alluding to postrtanscriptional control of TfR1 expression in CLL. The almost uniformly high CD71 expression in CLL is in keeping with the activated status of neoplastic cells, regardless of IGH mutational load. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect